Results 11 to 20 of about 96,303 (248)

How Does the Public Receive Information about Vaccines during the COVID-19 Pandemic? A Nationwide Cross-Sectional Study in Spain

Societies, 2023
Spain has been one of the most severely impacted countries by COVID-19. Vaccination against COVID-19 is one of the most successful preventive strategies.
Daniel Catalan-Matamoros, Andrea Langbecker   +1 more
doaj   +1 more source

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals

Frontiers in Immunology, 2023
IntroductionIn Hungary, the HUN-VE 3 study determined the comparative effectiveness of various primary and booster vaccination strategies during the Delta COVID-19 wave.
Zoltán Szekanecz, Zoltán Vokó, Zoltán Vokó, Orsolya Surján, Éva Rákóczi, Szilvia Szamosi, Gabriella Szűcs, Éva Szekanecz, Cecília Müller, Zoltán Kiss   +9 more
doaj   +1 more source

Studies on composite solid propellant with tri-modal ammonium perchlorate containing an ultrafine fraction

Defence Technology, 2017
Composite solid propellant is prepared using tri-modal Ammonium perchlorate (AP) containing coarse, fine and ultrafine fractions of AP with average particle size (APS) 340, 40 and 5 μm respectively, in various compositions and their rheological ...
K.V. Suresh Babu, P. Kanaka Raju, C.R. Thomas, A. Syed Hamed, K.N. Ninan   +4 more
doaj   +1 more source

Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients

Frontiers in Oncology, 2022
IntroductionEvidence is scant regarding the long-term humoral and cellular responses Q7 triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in cancer patients after repeated booster doses.
Javier David Benitez Fuentes, Kauzar Mohamed Mohamed, Alicia de Luna Aguilar, Carlos Jiménez García, Kissy Guevara-Hoyer, Kissy Guevara-Hoyer, Miguel Fernandez-Arquero, Miguel Fernandez-Arquero, M Antonia Rodríguez de la Peña, Laura Garciía Bravo, Alejandro Francisco Jiménez Ortega, Paloma Flores Navarro, Jorge Bartolome Arcilla, Bárbara Alonso Arenilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren García-Campero, María Montealegre Sanz, Silvia Sanchez-Ramon, Silvia Sanchez-Ramon, Pedro Perez Segura   +19 more
doaj   +1 more source

Awareness and Acceptance for COVID-19 Booster Dose Vaccination among Residents of Saudi Arabia: Findings of a Cross-Sectional Study

Vaccines, 2023
Background: In the global effort to combat SARS CoV2 infection, adoption of the vaccination has been an essential component. The goal of this research was to determine the quality of web-based information gathered during COVID-19 and participants ...
Mohammad Shakil Ahmad, Tayseer Dhayfallah Almuteri, Abdulrahman Obaid Matar Alharbi, Abdullah Tawakul, Mohammed Abdulrahman Mohammed Alturiqy, Mansour Alzahrani, Shaden Bader Almutairi, Ghadah Mohammed Almutairi, Aseel Saleh Alotaibi, Nouf Sultan Almutairi, Lama Khalid Alhabdan, Waleed Khalid Z Alghuyaythat   +11 more
doaj   +1 more source

Psychological and lifestyle risk factors for asthma exacerbations and morbidity in children

World Allergy Organization Journal, 2017
Asthma is the most common childhood illness and disproportionately affects low-income, minority children who live in urban areas. A range of risk factors are associated with asthma morbidity and mortality, such as treatment non-adherence, exposure to ...
Alyssa A. Oland, Genery D. Booster, Bruce G. Bender   +2 more
doaj   +1 more source

Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan

Vaccines, 2023
Booster vaccination reduces the incidence of severe cases and mortality related to COVID-19, with cellular immunity playing an important role. However, little is known about the proportion of the population that has achieved cellular immunity after ...
Yuta Tani, Morihito Takita, Yurie Kobashi, Masatoshi Wakui, Tianchen Zhao, Chika Yamamoto, Hiroaki Saito, Moe Kawashima, Sota Sugiura, Yoshitaka Nishikawa, Fumiya Omata, Yuzo Shimazu, Takeshi Kawamura, Akira Sugiyama, Aya Nakayama, Yudai Kaneko, Tetsuhiko Kodama, Masahiro Kami, Masaharu Tsubokura   +18 more
doaj   +1 more source

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly

Vaccines, 2023
Background: We analyzed coronavirus disease 2019 (COVID-19) vaccine efficacy in older persons who received the second booster compared to unvaccinated people and those receiving only a single COVID-19 vaccine booster. Methods: We collected information on
Camilla Mattiuzzi, Giuseppe Lippi
doaj   +1 more source

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia

Viruses, 2023
Vaccine efficacy against SARS-CoV-2 could be compromised by the emergence of SARS-CoV-2 variants and it is important to study how it impacts the booster vaccination regime.
Jolene Yin Ling Fu, Muhammad Harith Pukhari, Maria Kahar Bador, I-Ching Sam, Yoke Fun Chan   +4 more
doaj   +1 more source

COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects

Vaccines, 2022
In the light of the lack of authorized COVID-19 vaccines adapted to the Omicron variant lineage, the administration of the first and second booster dose is recommended.
Dorota Zarębska-Michaluk, Chenlin Hu, Michał Brzdęk, Robert Flisiak, Piotr Rzymski   +4 more
doaj   +1 more source